Determinants of inertia with lipid-lowering treatment in patients with type 2 diabetes mellitus.

Objective: To assess the control of cLDL in diabetic patients, to measure the impact on such control of inertia with lipid-lowering agents and to explore factors that allow for predicting this inertia.

Methods: Study of historical cohorts of diabetic patients. The proportion of patients who achieved the target cLDL levels was estimated.

Determinants of adherence to hypoglycemic agents and medical visits in patients with type 2 diabetes mellitus.

Aim: To assess glycemic control in diabetic patients, to measure the impact on such control of adherence to hypoglycemic agents and to medical visits, and to explore factors that allow for predicting adherence.

Methods: Study of historical cohorts of diabetic patients. The proportion of patients who achieved the target HbA levels was estimated.

The occurrence or fibrillary glomerulonephritis in patients with diabetes mellitus may not be coincidental: a report of four cases.

Although clinical presentation of fibrillary glomerulonephritis is similar to most forms of glomerulonephritis, it is usually difficult to make the diagnosis. Clinical manifestations include proteinuria, microscopic haematuria, nephrotic syndrome, and impairment of renal function. A diagnosis of fibrillary glomerulonephritis is only confirmed by renal biopsy and it must comprise electronmicroscopy-verified ultrastructural findings.